Breadcrumb

Submitting comments on IQWiG's assessments

You can comment on intermediate stages of our assessments and point out further aspects or missing data. A public commenting procedure (= hearing) is conducted after publication of the following documents:

  • report plans
  • preliminary reports

Further opportunities to submit comments

You can find topics currently suggested for HTA reports on our website ThemenCheck-Medizin.iqwig.de (in German). On this website, you can ask your questions for research and submit topics for assessments of examination and treatment methods.

Commenting procedures are also conducted for early benefit assessments of drugs pursuant to AMNOG (dossier assessments), for assessments of the potential of non-drug interventions, and for assessments pursuant to §137h SGB V. However, these are not conducted by IQWiG, but by the Federal Joint Committee (G-BA). The G-BA’s website provides information on these commenting procedures (see links below).

You can find more information on current IQWiG commenting procedures on the homepage of our website and via the German-language IQWiG information service, which you can subscribe to free of charge and in relation to specific projects.

Current commenting procedures


NoTitleTypeDeadline
A19-10Benefit assessment of bisphosphonates, teriparatide and denosumab for the treatment of postmenopausal osteoporosis zum Berichtsplan 14.01.2020

Save result list

To save your search result, please copy the link below and paste it into a new tab/window.

close